期刊文献+

膀胱移行细胞癌患者人类白细胞抗原G的表达及其与临床病理学特征的相关性 被引量:2

Expression of HLA-G and its correlation with clinicopathological characteristics of bladder transitional carcinoma
下载PDF
导出
摘要 目的探讨膀胱移行细胞癌组织中人类白细胞抗原G(HLA-G)的表达及其与临床病理特征的关系。方法选取62例膀胱移行细胞癌手术切除标本组织,另取术中癌旁正常膀胱黏膜组织标本作为对照,采用免疫组织化学Envision方法检测两种组织中HLA-G的表达情况,并分析其与临床病理特征的关系。结果 62例膀胱移行细胞癌患者中43例(69.4%)HLA-G阳性表达,20例癌旁正常膀胱黏膜组织中均未见HLA-G阳性表达。HLA-G的表达水平与膀胱移行细胞癌患者性别、年龄、肿瘤数目、临床分期、组织学分级均无明显相关性(均P>0.05)。结论膀胱移行细胞癌组织中HLA-G表达上调,HLA-G高表达与膀胱移行细胞临床病理特征无关。 Objective To investigate the expression of HLA- G in bladder transitional carcinoma (BTCC) and its correlation with clinicopathological characteristics Methods Envision immunohistochemistry analysis was performed to evaluate the ex-pression of HLA- G in 62 cases of bladder transitional carcinoma and 20 cases of tumor- adjacent normal bladder mucosa tissue. The correlation of HLA- G protein expression with clinicopathological characteristics was analyzed. Results The positive rate of HLA- G expression in BTCC was 69.4%(43/62), while no positive HLA- G expression(0/20)was found in normal bladder mucosa. HLA- G expression was not correlated with sex, age, tumor number, grade, stage (P〉0.05) in BTCC. Conclusion HLA- G ex-pression is commonly up- regulated in BTCC, which is not associated with clinicopathological characteristics of BTCC.
出处 《浙江医学》 CAS 2013年第13期1254-1256,共3页 Zhejiang Medical Journal
关键词 膀胱癌 疫组织化学 HLA-G Bladder cancer Immunohistochemistry HLA-G
  • 相关文献

参考文献13

  • 1Gomes A Q,Correia D V,Silva-Santos B, Non-classical major histocompatibility complex proteins as determinants of tumour immunosurveillance[J].EMBO Reports,2007, 8( 11 ): 1024-1030.
  • 2Pavelee Q, Zeuthen J, Kiessling R. Eseapefromhost-antitumorim- munity[J].Crit Rev Oncol,1997,8:111-141.
  • 3Seliger B, Schlaf G. Structure, expression and function of HLA-G in renal cell carcinoma[J].Semin Cancer Biol, 2007,17:444-450.
  • 4Rebmann V, Wagner S, Grosse-Wilde H. HLA-G expression in malignant melanoma[J].Semin Cancer Biol, 2007,17(6):422-429.
  • 5Palmisano G L, Pistillo M P, Fardin P, et al. Analysis of HLA-G expression in breast cancer tissues[J]. Hum Immunol, 2002, 63 (11 ):969-976.
  • 6Yan W H, Lin A, Chen B G, et al. Unfavourable clinical implica- tions for HLA-G expression in acute myeloid leukaemia[J]. J Cell Mol Med,2008,12(3):889-898.
  • 7Li B L, Lin A, Zhang X J, et al. Characterization of HLA-G ex- pression in renal cell carcinoma [J].Tissue Antigens,2009,74(3): 213-221.
  • 8Lin A, Zhang X, Zhou W J, et al. Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma[J]. Int J Cancer, 2011,129 (6): 1382-1390.
  • 9Rouas-Freiss N, Moreau P, Menier C, et al. Expression of tolerogenic HLA-G molecules in cancer prevents antitumor re- sponses[J].Semin Cancer Biol, 2007,17(6):413-421.
  • 10Chang C C, Campoli M ,Ferrone S. HLA class I antigen expres- sion in malignant cells : why does it not always correlate with CTL-mediated lysis[J]. Curr Opin Immunol, 2004,16:644-650.

同被引文献14

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部